• FBRX Stock Rallies 78% on Positive Early-Stage Vitiligo Study Data Zacks Investment Research Fri, 10 Jul 2026 13:34:10 GMT
• Forte Biosciences: FB102 Is Becoming A Platform Story, Not A Single-Indication Bet (NASDAQ:FBRX) Seeking Alpha Fri, 10 Jul 2026 12:25:00 GMT
• Forte’s FB102 achieves statistically-significant improvement in vitiligo The Pharma Letter Fri, 10 Jul 2026 11:48:45 GMT
• Forte Biosciences reports positive results from Phase Ib trial for vitiligo Yahoo Fri, 10 Jul 2026 10:37:52 GMT
• FBRX Stock On Track For Biggest Single-Day Gains In 20 Months – What’s Behind The Super Rally? TradingView Thu, 09 Jul 2026 17:06:21 GMT
• Forte Biosciences Skin Pigmentation Disorder Drug Shows Strong Efficacy, Safety In Early Study Benzinga Thu, 09 Jul 2026 16:26:24 GMT
• Forte Biosciences’ FB102 shows efficacy in vitiligo Phase 1b study TipRanks Thu, 09 Jul 2026 15:56:14 GMT
• Forte Bio surges on trial data for vitiligo drug (FBRX:NASDAQ) Seeking Alpha Thu, 09 Jul 2026 15:16:43 GMT
• Market movers: Forte Biosciences, Micron Technology, Simply Good Foods, PepsiCo… Proactive financial news Thu, 09 Jul 2026 14:30:00 GMT
• Forte Biosciences Shares Climb After Positive Phase 1b Vitiligo Trial Results (FBRX) Yahoo Finance Thu, 09 Jul 2026 14:09:25 GMT
• Forte Biosciences shares surge after positive phase 1b vitiligo results Proactive financial news Thu, 09 Jul 2026 13:26:00 GMT
• Enovix, Forte Biosciences rally premarket; PepsiCo slips By Investing.com Investing.com UK Thu, 09 Jul 2026 12:34:00 GMT
• Forte Biosciences stock jumps on positive vitiligo trial data Investing.com Thu, 09 Jul 2026 12:17:53 GMT
• Forte Biosciences reports positive Phase 1b vitiligo data for FB102 with 29.6% mean FVASI improvement TradingView Thu, 09 Jul 2026 12:13:01 GMT
• Forte’s skin-disease drug showed measured gains through week 24 Stock Titan Thu, 09 Jul 2026 12:00:00 GMT
• Federated Hermes (FBRX) shows 2.11M-share, 10.31% Schedule 13G/A stake Stock Titan Wed, 08 Jul 2026 11:43:06 GMT
• Certain Options of Forte Biosciences, Inc. are subject to a Lock-Up Agreement Ending on 8-JUL-2026. marketscreener.com Wed, 08 Jul 2026 00:24:09 GMT
• Forte Biosciences Inc focuses on dermatology pipeline as investors weigh long-term prospects AD HOC NEWS Tue, 07 Jul 2026 16:51:24 GMT
• RSU vesting boosts holdings at Forte Biosciences (NASDAQ: FBRX) Stock Titan Mon, 06 Jul 2026 20:04:38 GMT
• (FBRX) Movement Within Algorithmic Entry Frameworks Stock Traders Daily Thu, 02 Jul 2026 13:52:01 GMT
• Forte Biosciences Q1 2026 Earnings: Wider-Than-Expected Loss Amid Pre-Revenue Stage - Quarterly Financial Update dars.gov.et Wed, 01 Jul 2026 10:41:14 GMT
• Enterprise value to EBIT forward of Forte Biosciences, Inc. – NASDAQ:FBRX TradingView Tue, 30 Jun 2026 19:18:28 GMT
• Forte Biosciences, Inc.(NasdaqCM:FBRX) added to Russell Small Cap Comp Growth Benchmark marketscreener.com Mon, 29 Jun 2026 21:09:09 GMT
• Forte Biosciences, Inc.(NasdaqCM: FBRX) added to Russell 2000 Index marketscreener.com Mon, 29 Jun 2026 18:53:21 GMT
• Forte Biosciences, Inc.(NasdaqCM: FBRX) added to Russell Small Cap Completeness Index marketscreener.com Sun, 28 Jun 2026 22:00:00 GMT
• Forte Biosciences, Inc.(NasdaqCM: FBRX) dropped from Russell 3000E Value Benchmark marketscreener.com Sun, 28 Jun 2026 07:00:00 GMT
• FBRX Q1 2026 Earnings: EPS Misses Estimates, No Revenue Reported, Stock Gains 2.15% - Earnings Deceleration Risk dars.gov.et Thu, 25 Jun 2026 02:48:15 GMT
• forte biosciences inc (fbrx) financial health: profitability & balance sheet analysis TradingKey Wed, 24 Jun 2026 07:13:18 GMT
• forte biosciences inc (fbrx) valuation: pe, pb & fair value analysis TradingKey Wed, 24 Jun 2026 07:00:00 GMT
• forte biosciences inc (fbrx) technical analysis: support, resistance, indicators & moving averages TradingKey Wed, 24 Jun 2026 07:00:00 GMT
• forte biosciences inc (fbrx) valuation: pe, pb & fair value analysis TradingKey Mon, 22 Jun 2026 07:00:00 GMT
• forte biosciences inc (fbrx) financial health: profitability & balance sheet analysis TradingKey Thu, 18 Jun 2026 01:20:57 GMT
• forte biosciences inc (fbrx) technical analysis: support, resistance, indicators & moving averages TradingKey Thu, 18 Jun 2026 01:19:09 GMT
• forte biosciences inc (fbrx) risk assessment: volatility, financial risk & investment risk TradingKey Thu, 18 Jun 2026 01:18:26 GMT
• forte biosciences inc (fbrx) valuation: pe, pb & fair value analysis TradingKey Thu, 18 Jun 2026 00:54:11 GMT
• forte biosciences inc (fbrx) dividends & stock splits: historical payouts and event timeline TradingKey Wed, 17 Jun 2026 15:51:04 GMT
• forte biosciences inc (fbrx) shareholder structure: major shareholders & institutional holdings TradingKey Wed, 17 Jun 2026 15:49:52 GMT
• Forte Biosciences Inc (FBRX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution TradingKey Wed, 17 Jun 2026 15:49:11 GMT
• Forte Biosciences (FBRX) CFO receives 22,000 stock options grant Stock Titan Wed, 17 Jun 2026 07:00:00 GMT
• forte biosciences (fbrx) awards 500,000 stock options to insider wagner Stock Titan Wed, 17 Jun 2026 07:00:00 GMT
• forte biosciences (fbrx) dips nearly 5%: testing key support at $16.29 - revenue weighted newsline.com Tue, 16 Jun 2026 23:34:03 GMT
• One Forte Biosciences Insider Raised Stake By 30% In Previous Year Yahoo Finance Sat, 13 Jun 2026 07:00:00 GMT
• fbrx q1 2026 earnings: wider-than-expected loss as biotech continues development - margin guidance newsline.com Wed, 10 Jun 2026 18:42:26 GMT
• Forte Biosciences (FBRX) Gains 5%: Support and Resistance Levels in Focus - Wave Extension dars.gov.et Wed, 10 Jun 2026 07:00:00 GMT
• Millennium Group (FBRX) reports shared control of 1,062,182 shares Stock Titan Mon, 08 Jun 2026 07:00:00 GMT
• Forte Biosciences | S-3/A: Registration statement for specified transactions by certain issuers (Amendment) Moomoo Mon, 08 Jun 2026 07:00:00 GMT
• forte biosciences (fbrx) edges lower amid sector volatility, key support holds - smart money flow stocks newsline.com Sun, 07 Jun 2026 14:33:24 GMT
• number of shareholders of forte biosciences inc. – gettex:37t TradingView Sat, 06 Jun 2026 23:45:18 GMT
• Forte Biosciences (FBRX) Slips 1% as Stock Consolidates Between Key Support and Resistance - Golden Cross dars.gov.et Sat, 06 Jun 2026 07:00:00 GMT
• forte biosciences (nasdaq: fbrx) files $500m shelf to sell securities Stock Titan Fri, 05 Jun 2026 07:00:00 GMT
• forte biosciences (nasdaq: fbrx) director receives 18,353 rsu equity award Stock Titan Tue, 02 Jun 2026 07:00:00 GMT
• forte biosciences (fbrx) director granted 18,353 rsus in equity award Stock Titan Tue, 02 Jun 2026 07:00:00 GMT
• forte biosciences (fbrx) director awarded 18,353 restricted stock units in equity grant Stock Titan Tue, 02 Jun 2026 07:00:00 GMT
• director at forte biosciences (nasdaq: fbrx) awarded 18,353 rsus as equity grant Stock Titan Tue, 02 Jun 2026 07:00:00 GMT
• insider buyers lose additional us$69k as forte biosciences dips to us$466m Moomoo Tue, 02 Jun 2026 07:00:00 GMT
• forte biosciences (fbrx) stockholders approve amended 2021 equity incentive plan Stock Titan Tue, 02 Jun 2026 07:00:00 GMT
• forte biosciences shareholders approve directors and governance items TipRanks Tue, 02 Jun 2026 07:00:00 GMT
• forte biosciences (fbrx) awards 18,353 rsus to director steven kornfeld Stock Titan Tue, 02 Jun 2026 07:00:00 GMT
• forte biosciences (nasdaq: fbrx) files $500m shelf; highlights fb102 clinical wins Stock Titan Tue, 02 Jun 2026 07:00:00 GMT
• fbrx q1 2026 earnings: eps misses estimates as pre-revenue biotech continues clinical progress newsline.com Mon, 01 Jun 2026 07:00:00 GMT
• forte biosciences (fbrx) price target increased by 19.72% to 65.02 MSN Mon, 01 Jun 2026 00:31:20 GMT
• Forte Biosciences Slides As Insider Purchases Lose Another US$70k simplywall.st Sat, 30 May 2026 07:00:00 GMT
• forte biosciences (fbrx) tumbles 8% as bears test support at $18.12 - insider buying alerts newsline.com Sat, 30 May 2026 07:00:00 GMT
• forte biosciences inc stock (us34960p1012): shares slip after recent q1 loss and high volatility Ad-hoc-news.de Fri, 29 May 2026 07:00:00 GMT
• fbrx q1 2026 earnings: narrower loss but clinical path remains uncertain - long-term guidance The Legal Advocate Sun, 24 May 2026 21:42:12 GMT
• fbrx q1 2026 earnings: pre-revenue biotech reports narrow eps miss amid ongoing development - surprise factor analysis newsline.com Sun, 24 May 2026 07:00:00 GMT
• forte biosciences q1 2026 earnings: pre-revenue biotech misses eps estimates; stock dips on narrower loss miss - tech earnings ana... The Legal Advocate Sat, 23 May 2026 07:00:00 GMT
• fbrx q1 2026 earnings: wider-than-expected loss reflects pre-revenue biotech reality - earnings volatility report newsline.com Fri, 22 May 2026 07:00:00 GMT
• fbrx stock price, quote & chart | forte biosciences inc (nasdaq:fbrx) ChartMill Fri, 22 May 2026 07:00:00 GMT
• chardan capital maintains forte biosciences(fbrx.us) with buy rating, maintains target price $61 富途牛牛 Thu, 21 May 2026 09:03:47 GMT
• forte biosciences stock (us34960p1012): q1 update keeps focus on skin disease pipeline AD HOC NEWS Thu, 21 May 2026 07:00:00 GMT
• forte biosciences (fbrx) q1 2026 results fall short — eps $-1.24, revenue $n/a - revenue warning signal newsline.com Wed, 20 May 2026 07:00:00 GMT
• forte biosciences inc stock (us34960p1012): clinical pivot and cash focus keep biotech investors ale Ad-hoc-news.de Tue, 19 May 2026 07:00:00 GMT
• (fbrx) and the role of price-sensitive allocations Stock Traders Daily Tue, 19 May 2026 07:00:00 GMT
• forte biosciences (fbrx) price target increased by 19.72% to 65.02 MSN Mon, 18 May 2026 21:26:45 GMT
• forte biosciences (fbrx) price target increased by 19.72% to 65.02 MSN Sun, 17 May 2026 23:54:34 GMT
• forte biosciences stock (us34960p1012): volatile biotech after recent sell-off tests investor nerves AD HOC NEWS Sun, 17 May 2026 18:44:54 GMT
• Forte Biosciences Stock: Targeting Celiac Disease (NASDAQ:FBRX) Seeking Alpha Sat, 16 May 2026 07:00:00 GMT
• forte biosciences stock (us34960p1012): new 13g filings highlight major holders AD HOC NEWS Sat, 16 May 2026 07:00:00 GMT
• forte biosciences (fbrx) price target increased by 19.72% to 65.02 MSN Sat, 16 May 2026 06:54:13 GMT
• mpm bioimpact llc takes a 7.2% position in forte biosciences (nasdaq: fbrx) Stock Titan Fri, 15 May 2026 07:00:00 GMT
• janus henderson (fbrx) discloses 9.99% holding; 299,798 pre-funded warrants Stock Titan Fri, 15 May 2026 07:00:00 GMT
• orbimed entities hold 5.8% of forte biosciences (fbrx), ownership split disclosed Stock Titan Fri, 15 May 2026 07:00:00 GMT
• alger associates (nasdaq: fbrx) reports 1.27m shares; 10.2% stake Stock Titan Fri, 15 May 2026 07:00:00 GMT
• point72 entities report 0% ownership in forte biosciences (fbrx) Stock Titan Fri, 15 May 2026 07:00:00 GMT
• forte biosciences (fbrx) price target increased by 19.72% to 65.02 MSN Thu, 14 May 2026 12:23:04 GMT
• Forte Biosciences (NASDAQ: FBRX) deepens Q1 loss while FB102 wins Fast Track Stock Titan Thu, 14 May 2026 07:00:00 GMT
• forte biosciences stock (us34960p1012): q1 2026 earnings report upcoming Ad-hoc-news.de Thu, 14 May 2026 07:00:00 GMT
• affinity asset advisors takes 7.3% stake in forte biosciences (nasdaq: fbrx) Stock Titan Thu, 14 May 2026 07:00:00 GMT
• Forte Biosciences Inc reports results for the quarter ended March 31 - Earnings Summary TradingView Wed, 13 May 2026 07:00:00 GMT
• adage (fbrx) files schedule 13g reporting 950,000-share stake Stock Titan Wed, 13 May 2026 07:00:00 GMT
• fbrx technical analysis | trend, signals & chart patterns | forte biosciences inc (nasdaq:fbrx) ChartMill Wed, 13 May 2026 07:00:00 GMT
• chardan capital maintains forte biosciences(fbrx.us) with buy rating, maintains target price $61 Moomoo Tue, 12 May 2026 07:43:59 GMT
• forte biosciences stock (us34960p1012): q1 2026 results and fda fast track for fb102 AD HOC NEWS Tue, 12 May 2026 07:00:00 GMT
• chardan capital maintains forte biosciences(fbrx.us) with buy rating, maintains target price $61 Moomoo Mon, 11 May 2026 22:31:00 GMT
• td cowen maintains forte biosciences(fbrx.us) with buy rating Moomoo Mon, 11 May 2026 21:32:00 GMT
• forte biosciences grants 66,667 rsus to new employee as inducement geneonline.com Mon, 11 May 2026 20:50:00 GMT
• forte biosciences q1 net loss narrows as r&d spending rises TradingView Mon, 11 May 2026 13:10:46 GMT
• forte biosciences, inc. announces first quarter 2026 results and provides update The Joplin Globe Mon, 11 May 2026 13:03:12 GMT
• forte biosciences, inc. reports earnings results for the first quarter ended march 31, 2026 marketscreener.com Mon, 11 May 2026 13:02:00 GMT
• fda fast-tracks celiac treatment as forte biosciences raises $172m Stock Titan Mon, 11 May 2026 07:00:00 GMT
• fbrx financials: income statement, balance sheet & cash flow Stock Titan Mon, 11 May 2026 07:00:00 GMT
• forte biosciences, inc. 1q 2026: net loss $(22.1m), diluted eps $(1.24) — 10-q summary TradingView Mon, 11 May 2026 07:00:00 GMT
• forte biosciences (fbrx) widens q1 loss and raises $172.5m to fund fb102 trials Stock Titan Mon, 11 May 2026 07:00:00 GMT
• new forte biosciences hire gets 50k options, 50k rsus to join Stock Titan Mon, 11 May 2026 07:00:00 GMT
• forte biosciences: buy rating backed by fb102 pipeline momentum and multiple upcoming clinical catalysts TipRanks Mon, 11 May 2026 07:00:00 GMT
• forte biosciences, inc. reports inducement grant under nasdaq listing rules Quantisnow Mon, 11 May 2026 07:00:00 GMT
• evercore maintains forte biosciences(fbrx.us) with buy rating, maintains target price $65 富途牛牛 Tue, 05 May 2026 19:31:00 GMT
• what forte biosciences (fbrx) is doing to earn customer loyalty (breakdown watch) 2026-05-05 - adaptive moving average newsline.com Tue, 05 May 2026 07:00:00 GMT
• wall street zen upgrades forte biosciences (nasdaq:fbrx) to "sell" MarketBeat Sat, 02 May 2026 05:56:32 GMT
• stock traders purchase high volume of call options on forte biosciences (nasdaq:fbrx) MarketBeat Thu, 30 Apr 2026 08:35:59 GMT
• forte biosciences | def 14a: definitive information statements Moomoo Wed, 29 Apr 2026 20:43:31 GMT
• forte biosciences (nasdaq: fbrx) 2026 proxy seeks approval of larger equity plan Stock Titan Wed, 29 Apr 2026 07:00:00 GMT
• is forte biosciences (fbrx) stock respecting technical levels | q4 2025: earnings fall short - earnings preview newsline.com Mon, 27 Apr 2026 07:00:00 GMT
• understanding the setup: (fbrx) and scalable risk Stock Traders Daily Mon, 27 Apr 2026 07:00:00 GMT
• forte biosciences prices 5.71m shares at $26.27 in $150m capital raise MSN Fri, 24 Apr 2026 04:36:44 GMT
• forte biosciences launches public stock offering to fund operations MSN Thu, 23 Apr 2026 12:57:23 GMT
• forte biosciences prices 5.71m shares at $26.27 in $150m capital raise MSN Thu, 23 Apr 2026 10:33:08 GMT
• fbrx (forte biosciences inc.) reports wider than expected q4 2025 loss, with shares falling 3.52% following the earnings release. ... Xã Thanh Hà Thu, 23 Apr 2026 04:07:18 GMT
• fbrx (forte biosciences inc.) reports wider than expected q4 2025 loss, with shares falling 3.52% following the earnings release. ... Cổng thông tin điện tử tỉnh Tây Ninh Wed, 22 Apr 2026 18:20:16 GMT
• fbrx financials: income statement, balance sheet & cash flow Stock Titan Wed, 22 Apr 2026 01:58:11 GMT
• forte biosciences inc stock (us34960p1012): is its immunology focus strong enough to unlock biotech AD HOC NEWS Sat, 18 Apr 2026 12:41:05 GMT
• forte biosciences, inc. (nasdaq:fbrx) short interest update MarketBeat Thu, 16 Apr 2026 07:00:00 GMT
• forte biosciences sees unusually large options volume (nasdaq:fbrx) MarketBeat Thu, 16 Apr 2026 07:00:00 GMT
Forte Biosciences, Inc.(NASDAQ:FBRX) 
Forte Biosciences Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing a live biotherapeutic FB-401 that has completed Phase 1/2a clinical trial to treat inflammatory skin diseases for pediatric atopic dermatitis patients. The company was incorporated in...
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends